Evan Davies

483 total citations
31 papers, 366 citations indexed

About

Evan Davies is a scholar working on Pulmonary and Respiratory Medicine, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Evan Davies has authored 31 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Economics and Econometrics and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Evan Davies's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Pulmonary Hypertension Research and Treatments (7 papers) and Healthcare cost, quality, practices (4 papers). Evan Davies is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Pulmonary Hypertension Research and Treatments (7 papers) and Healthcare cost, quality, practices (4 papers). Evan Davies collaborates with scholars based in United States, United Kingdom and Switzerland. Evan Davies's co-authors include Louis S. Matza, Katie D. Stewart, Kristina S. Boye, David Feeny, Rosirene Paczkowski, Jessica Jordan, Sarah Curtis, Jiat Ling Poon, Amélie Beaudet and Heather L. Gelhorn and has published in prestigious journals such as Spine, Quality of Life Research and BMC Health Services Research.

In The Last Decade

Evan Davies

30 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evan Davies United States 10 112 90 74 62 44 31 366
Tanya Burton United States 11 73 0.7× 154 1.7× 54 0.7× 108 1.7× 47 1.1× 32 507
Belén Marrón Spain 10 52 0.5× 50 0.6× 65 0.9× 81 1.3× 42 1.0× 29 433
Josh Benner United States 3 144 1.3× 51 0.6× 39 0.5× 56 0.9× 30 0.7× 3 575
Anneke Kramer Netherlands 18 110 1.0× 45 0.5× 94 1.3× 99 1.6× 71 1.6× 46 784
Radhika Kanthety United States 7 62 0.6× 32 0.4× 39 0.5× 46 0.7× 29 0.7× 8 358
Koo Wilson Sweden 14 153 1.4× 23 0.3× 56 0.8× 74 1.2× 47 1.1× 44 547
J. del Llano Spain 6 116 1.0× 32 0.4× 41 0.6× 48 0.8× 45 1.0× 9 365
Francisco Coronel Spain 14 33 0.3× 74 0.8× 73 1.0× 116 1.9× 16 0.4× 60 548
Nazila Assasi Canada 14 137 1.2× 28 0.3× 26 0.4× 41 0.7× 69 1.6× 32 412
Marc A G J ten Dam Netherlands 11 47 0.4× 37 0.4× 58 0.8× 49 0.8× 73 1.7× 24 484

Countries citing papers authored by Evan Davies

Since Specialization
Citations

This map shows the geographic impact of Evan Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Davies more than expected).

Fields of papers citing papers by Evan Davies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Davies. The network helps show where Evan Davies may publish in the future.

Co-authorship network of co-authors of Evan Davies

This figure shows the co-authorship network connecting the top 25 collaborators of Evan Davies. A scholar is included among the top collaborators of Evan Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan Davies. Evan Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trundell, Dylan, Evan Davies, Stefano Zanigni, et al.. (2025). Estimation of and clinical consensus on the meaningful motor progression threshold on MDS-UPDRS Part III. Journal of Parkinson s Disease. 15(1). 97–110. 2 indexed citations
2.
Pagano, Gennaro, Dylan Trundell, Tanya Simuni, et al.. (2025). Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials. npj Parkinson s Disease. 11(1). 193–193.
4.
5.
Talbot, George H., Leah Kleinman, Evan Davies, et al.. (2019). Clostridium difficile Infection–Daily Symptoms (CDI-DaySyms™) questionnaire: psychometric characteristics and responder thresholds. Health and Quality of Life Outcomes. 17(1). 77–77. 4 indexed citations
7.
Matza, Louis S., Karen Chung, Trena M. Paulus, et al.. (2017). Risks associated with antiretroviral treatment for human immunodeficiency virus (HIV): qualitative analysis of social media data and health state utility valuation. Quality of Life Research. 26(7). 1785–1798. 7 indexed citations
9.
Matza, Louis S., Katie D. Stewart, Evan Davies, et al.. (2016). Health State Utilities Associated with Glucose Monitoring Devices. Value in Health. 20(3). 507–511. 34 indexed citations
10.
Gelhorn, Heather L., Jiat Ling Poon, Evan Davies, et al.. (2015). Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK. Patient Preference and Adherence. 9. 1611–1611. 47 indexed citations
11.
Matza, Louis S., Katie D. Stewart, Shravanthi R. Gandra, et al.. (2015). Acute and chronic impact of cardiovascular events on health state utilities. BMC Health Services Research. 15(1). 173–173. 51 indexed citations
12.
Davies, Evan, Louis S. Matza, David Feeny, et al.. (2015). Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis. Health and Quality of Life Outcomes. 13(1). 90–90. 29 indexed citations
13.
Matza, Louis S., Sandhya Sapra, John Dillon, et al.. (2014). Health state utilities associated with attributes of treatments for hepatitis C. The European Journal of Health Economics. 16(9). 1005–1018. 39 indexed citations
14.
Fenster, Brett E., et al.. (2014). Acute And Chronic Impact Of Cardiovascular Events On Health State Utilities. Value in Health. 17(7). A493–A493. 4 indexed citations
15.
Sapra, Sandhya, et al.. (2014). Health State Utilities Associated With Attributes Of Treatments For Hepatitis C. Value in Health. 17(3). A9–A9. 1 indexed citations
16.
Haynes, Virginia S., et al.. (2014). Health state utilities associated with adult attention-deficit/hyperactivity disorder. Patient Preference and Adherence. 8. 997–997. 8 indexed citations
18.
Matza, Louis S., Karen Chung, Kate Van Brunt, et al.. (2013). Health state utilities for skeletal-related events secondary to bone metastases. The European Journal of Health Economics. 15(1). 7–18. 24 indexed citations
19.
Matza, Louis S., et al.. (2012). PMS60 The Time Horizon Matters: Exploratory Results Varying the Time Horizon in Time Trade-Off and Standard Gamble Utility Elicitation. Value in Health. 15(7). A450–A450. 1 indexed citations
20.
Petrillo, Jennifer, et al.. (2009). PRS33 DEVELOPMENT OF A PREFERENCE-BASED ALGORITHM TO REPORT UTILITIES FOR EXACERBATIONS OF COPD FROM THE EXACT. Value in Health. 12(7). A304–A305. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026